(E) groups with expertise around overdose 
reversal; and 
(7) other stakeholders, as the Secretary deter-
mines appropriate. 
(c) DUTIES.—The task force shall— 
(1) not later than 180 days after the date on 
which the task force is convened under subsection 
(a), develop best practices for pain management and 
prescribing pain medication, taking into consider-
ation— 
(A) existing pain management research; 
(B) recommendations from relevant con-
ferences; and 
(C) ongoing efforts at the State and local 
levels and by medical professional organizations 
to develop improved pain management strate-
gies; 
(2) solicit and take into consideration public 
comment on the practices developed under para-
graph (1), amending such best practices if appro-
priate; and 
(3) develop a strategy for disseminating infor-
mation about the best practices developed under 
paragraphs (1) and (2) to prescribers, pharmacists, 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
State medical boards, and other parties, as the Sec-
retary determines appropriate. 
(d) LIMITATION.—The task force shall not have rule-
making authority. 
(e) REPORT.—Not later than 270 days after the date 
on which the task force is convened under subsection (a), 
the task force shall submit to Congress a report that in-
cludes— 
(1) the strategy for disseminating best practices 
developed under subsection (c); 
(2) the results of a feasibility study on linking 
best practices developed under subsection (c) to re-
ceiving and renewing registrations under section 
303(f) of the Controlled Substances Act (21 U.S.C. 
823(f)); and 
(3) recommendations on how to apply best 
practices developed under subsection (c) to improve 
prescribing practices at medical facilities, including 
medical facilities of the Veterans Health Administra-
tion. 
SEC. 102. NATIONAL EDUCATION CAMPAIGN. 
(a) DEFINITION.—In this section, the term ‘‘eligible 
entity’’ means a State, unit of local government, or non-
profit organization. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(b) PROGRAM AUTHORIZED.—Section 1177 of chap-
ter 16 of Drug Abuse Prevention, Treatment and Reha-
bilitation (21 U.S.C. chapter 16 subchapter IV) is amend-
ed— 
(1) by adding subsection 1177b and inserting 
the following: 
‘‘The Attorney General, in coordination with the Sec-
retary of Health and Human Services, the Director of the 
Office of National Drug Control Policy, the Secretary of 
Education, the Administrator of the Substance Abuse and 
Mental Health Services Administration, and the Director 
of the Centers for Disease Control and Prevention, may 
make grants to eligible entities to expand educational ef-
forts to prevent abuse of opioids, heroin, and other sub-
stances of abuse, understand addiction as a chronic dis-
ease, and promote treatment and recovery, including— 
‘‘(1) parent and caretaker-focused prevention 
efforts, including— 
‘‘(A) the development of research-based 
community education online and social media 
materials with an accompanying toolkit that 
can be disseminated to communities to educate 
parents and other caretakers of teens on— 
‘‘(i) how to educate teens about opioid 
and heroin abuse; 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(ii) how to intervene if a parent 
thinks or knows their teen is abusing 
opioids or heroin; 
‘‘(iii) signs of opioid or heroin over-
dose; and 
‘‘(iv) the use of naloxone to prevent 
death from opioid or heroin overdose; 
‘‘(B) the development of detailed digital 
and print educational materials to accompany 
the online and social media materials and tool-
kit described in subparagraph (A); 
‘‘(C) the development and dissemination of 
public service announcements to— 
‘‘(i) raise awareness of heroin and 
opioid abuse among parents and other 
caretakers; 
‘‘(ii) motivate parents and other care-
takers to visit online educational materials 
on heroin and opioid abuse; and 
‘‘(iii) provide information for public 
health agencies and nonprofit organiza-
tions that provide overdose reversal and 
prevention services and community refer-
rals; and 
VerDate Sep 11 2014 
02:04 Dec 31, 2014
Jkt 049200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(D) the dissemination of educational ma-
terials to the media through— 
‘‘(i) a town hall or panel discussion 
with experts; 
‘‘(ii) a press release; 
‘‘(iii) an online news release; 
‘‘(iv) a media tour; and 
‘‘(v) sharable infographics; 
‘‘(2) prevention efforts focused on teenagers, 
college students, and college-age individuals, includ-
ing— 
‘‘(A) the development of a national digital 
campaign; and 
‘‘(B) the development of a community edu-
cation toolkit for use by community coalitions; 
‘‘(3) campaigns to inform individuals about 
available resources to aid in recovery from substance 
use disorder; 
‘‘(4) encouragement of individuals in or seeking 
recovery from substance use disorder to enter the 
health care system; or 
‘‘(5) adult-focused awareness efforts, including 
efforts focused on older adults, relating to prescrip-
tion medication disposal, opioid and heroin abuse, 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
signs of overdose, and the use of naloxone for rever-
sal. 
‘‘(c) APPLICATION.— 
‘‘(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
‘‘(A) that meets the criteria under para-
graph (2); and 
‘‘(B) at such time, in such manner, and 
accompanied by such information as the Attor-
ney General may require. 
‘‘(2) CRITERIA.—An eligible entity, in submit-
ting an application under paragraph (1), shall— 
‘‘(A) describe the evidence-based method-
ology and outcome measurements that will be 
used to evaluate the program funded with a 
grant under this section; 
‘‘(B) specifically explain how the measure-
ments described in subparagraph (A) will pro-
vide valid measures of the impact of the pro-
gram described in subparagraph (A); 
‘‘(C) describe how the program described 
in subparagraph (A) could be broadly replicated 
if demonstrated to be effective; 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(D) demonstrate that all planned services 
will be research-informed, which may include 
evidence-based practices documented in— 
‘‘(i) the report of the Institute of 
Medicine 
entitled 
‘Preventing 
Mental, 
Emotional, 
and 
Behavioral 
Disorders 
Among Young People’; or 
‘‘(ii) the National Registry of Effec-
tive Programs and Practices (commonly re-
ferred to as ‘NREPP’ of the Substance 
Abuse and Mental Health Administration); 
and 
‘‘(E) demonstrate that the eligible entity 
will effectively integrate and sustain the pro-
gram described in subparagraph (A) into cur-
riculum or community outreach efforts. 
‘‘(d) USE OF FUNDS.—A grantee shall use a grant 
received under this section for expenses of educational ef-
forts to— 
‘‘(1) prevent abuse of opioids, heroin, alcohol, 
and other drugs; or 
‘‘(2) promote treatment and recovery. 
‘‘(e) DURATION.—The Attorney General shall award 
grants under this section for a period not to exceed 2 
years. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(f) INFORMATION SHARING.—The Office of the At-
torney General, in coordination with the Substance Abuse 
and Mental Health Services Administration and the De-
partment of Education, shall review existing evidence- 
based programs and emerging practices and programs and 
provide information to schools and communities about 
such programs and practices. 
‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$2,500,000 for each of fiscal years 2016 through 2020.’’. 
SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT 
GRANTS TO ADDRESS LOCAL DRUG CRISES. 
(a) DEFINITIONS.—In this section— 
(1) the term ‘‘Drug-Free Communities Act of 
1997’’ means chapter 2 of subtitle A of title I of the 
Anti-Drug Abuse Act of 1988 (21 U.S.C. 1521 et 
seq.); 
(2) the term ‘‘eligible entity’’ means an organi-
zation that— 
(A) on or before the date of submitting an 
application for a grant under this section, re-
ceives or has received a grant under the Drug- 
Free Communities Act of 1997; and 
(B) has documented, using local data, 
rates of abuse of opioids at levels that are— 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(i) significantly higher than the na-
tional average as determined by the Attor-
ney General (including appropriate consid-
eration of the Monitoring the Future Sur-
vey published by the National Institute on 
Drug Abuse and the National Survey on 
Drug Use and Health by the Substance 
Abuse and Mental Health Service Adminis-
tration); or 
(ii) higher than the national average, 
as determined by the Attorney General (in-
cluding appropriate consideration of the 
surveys described in clause (i)), over a sus-
tained period of time; and 
(3) the term ‘‘local drug crisis’’ means, with re-
spect to the area served by an eligible entity— 
(A) a sudden increase in the abuse of pre-
scription medications, specifically opioids, as 
documented by local data; or 
(B) the abuse of prescription medications, 
specifically opioids, that is significantly higher 
than the national average, over a sustained pe-
riod of time, as documented by local data. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(b) PROGRAM AUTHORIZED.—Section 1535 of chap-
ter 20 of the National Drug Control Program (21 U.S.C. 
chapter 20 subchapter II) is amended— 
(1) by adding subsection 1536 and inserting the 
following: 
‘‘The Attorney General, in coordination with the Di-
rector of the Office of National Drug Control Policy, may 
make grants to eligible entities to implement comprehen-
sive community-wide strategies that address local drug cri-
ses within the area served by the eligible entity.’’. 
(c) APPLICATION.— 
(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General at such time, in such man-
ner, and accompanied by such information as the 
Attorney General may require. 
(2) CRITERIA.—As part of an application for a 
grant under this section, the Attorney General shall 
require an eligible entity to submit a detailed, com-
prehensive, multisector plan for addressing the local 
drug crisis within the area served by the eligible en-
tity. 
(d) USE OF FUNDS.—An eligible entity shall use a 
grant received under this section— 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(1) for programs designed to implement com-
prehensive communitywide prevention strategies to 
address local drug crisis in the area served by the 
eligible entity, in accordance with the plan submitted 
under subsection (c)(2); and 
(2) to obtain specialized training and technical 
assistance from the organization funded under sec-
tion 4 of Public Law 107–82 (21 U.S.C. 1521 note). 
(e) GRANT AMOUNTS AND DURATION.— 
(1) AMOUNTS.—The Attorney General may not 
award a grant under this section for a fiscal year in 
an amount that exceeds— 
(A) the amount of non-Federal funds 
raised by the eligible entity, including in-kind 
contributions, for that fiscal year; or 
(B) $75,000. 
(2) DURATION.—The Attorney General shall 
award grants under this section for a period not to 
exceed 4 years. 
(f) SUPPLEMENT NOT SUPPLANT.—An eligible entity 
shall use Federal funds received under this section only 
to supplement the funds that would, in the absence of 
those Federal funds, be made available from other Federal 
and non-Federal sources for the activities described in this 
section, and not to supplant those funds. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(g) EVALUATION.—A grant under this section shall 
be subject to the same evaluation requirements and proce-
dures as the evaluation requirements and procedures im-
posed on the recipient of a grant under the Drug-Free 
Communities Act of 1997. 
(h) LIMITATION ON ADMINISTRATIVE EXPENSES.— 
Not more than 8 percent of the amounts made available 
pursuant to subsection (i) for a fiscal year may be used 
by the Attorney General to pay for administrative ex-
penses. 
(i) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of fiscal years 2016 through 2020. 
TITLE II—LAW ENFORCEMENT 
AND TREATMENT 
SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION 
PROGRAMS. 
(a) PROGRAM AUTHORIZED.—Strike 3797(q), Drug 
Treatment Alternatives to Prison (42 U.S.C. chapter 46), 
and insert: 
(b) DEFINITIONS.—In this section— 
(1) the term ‘‘eligible entity’’ means a State, 
unit of local government, Indian tribe, or nonprofit 
organization; and 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(2) the term ‘‘eligible participant’’ means an in-
dividual who— 
(A) comes into contact with the criminal 
justice system or is charged with an offense; 
(B) has a history of or a current— 
(i) substance use disorder; 
(ii) mental illness; or 
(iii) co-occurring mental illness and 
substance use disorders; and 
(C) has been approved for participation in 
a program funded under this section by, as ap-
plicable depending on the stage of the criminal 
justice process, the relevant law enforcement 
agency or defense attorney, probation or correc-
tions official, judge, or representative from the 
relevant mental health or substance abuse agen-
cy. 
(c) PROGRAM AUTHORIZED.—The Attorney General 
may make grants to eligible entities to develop, implement, 
or expand a treatment alternative to incarceration pro-
gram for eligible participants, including— 
(1) pre-booking treatment alternative to incar-
ceration programs, including— 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(A) law enforcement training on substance 
use disorders, mental illness, and co-occurring 
mental illness and substance use disorders; 
(B) receiving centers as alternatives to in-
carceration of eligible participants; 
(C) specialized response units for calls re-
lated to substance use disorders, mental illness, 
and co-occurring mental illness and substance 
use disorders; and 
(D) other arrest and prebooking treatment 
alternative to incarceration models; and 
(2) postbooking treatment alternative to incar-
ceration programs, including— 
(A) specialized clinical case management; 
(B) pretrial services related to substances 
use disorders, mental illness, and co-occurring 
mental illness and substance use disorders; 
(C) prosecutor- and defender-based pro-
grams; 
(D) specialized probation; 
(E) treatment and rehabilitation programs; 
and 
(F) drug courts, DWI courts, and veterans 
treatment courts. 
(d) APPLICATION.— 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
(A) that meets the criteria under para-
graph (2); and 
(B) at such time, in such manner, and ac-
companied by such information as the Attorney 
General may require. 
(2) CRITERIA.—An eligible entity, in submitting 
an application under paragraph (1), shall— 
(A) provide extensive evidence of collabora-
tion with State and local government agencies 
overseeing 
health, 
community 
corrections, 
courts, prosecution, substance abuse, mental 
health, victims services, and employment serv-
ices, and with local law enforcement agencies; 
(B) demonstrate consultation with the Sin-
gle State Authority for Substance Abuse; 
(C) demonstrate that evidence-based treat-
ment practices will be utilized; and 
(D) 
demonstrate 
that 
evidenced-based 
screening and assessment tools will be utilized 
to place participants in the treatment alter-
native to incarceration program. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(e) REQUIREMENTS.—Each eligible entity awarded a 
grant for a treatment alternative to incarceration program 
under this section shall— 
(1) determine the terms and conditions of par-
ticipation in the program by eligible participants, 
taking into consideration the collateral consequences 
of criminal conviction; 
(2) ensure that each substance abuse and men-
tal health treatment component is licensed and 
qualified by the relevant jurisdiction; 
(3) for programs described in subsection (b)(2), 
organize an enforcement unit comprised of appro-
priately trained law enforcement professionals under 
the supervision of the State, tribal, or local criminal 
justice agency involved, the duties of which shall in-
clude— 
(A) the verification of addresses and other 
contacts of each eligible participant who partici-
pates or desires to participate in the program; 
and 
(B) if necessary, the location, apprehen-
sion, arrest, and return to court of an eligible 
participant in the program who has absconded 
from the facility of a treatment provider or has 
otherwise violated the terms and conditions of 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
the program, consistent with Federal and State 
confidentiality requirements; 
(4) notify the relevant criminal justice entity if 
any eligible participant in the program absconds 
from the facility of the treatment provider or other-
wise violates the terms and conditions of the pro-
gram, consistent with Federal and State confiden-
tiality requirements; 
(5) submit periodic reports on the progress of 
treatment or other measured outcomes from partici-
pation in the program of each eligible offender par-
ticipating in the program to the relevant State, trib-
al, or local criminal justice agency; 
(6) describe the evidence-based methodology 
and outcome measurements that will be used to 
evaluate the program, and specifically explain how 
such measurements will provide valid measures of 
the impact of the program; and 
(7) describe how the program could be broadly 
replicated if demonstrated to be effective. 
(f) USE OF FUNDS.—An eligible entity shall use a 
grant received under this section for expenses of a treat-
ment alternative to incarceration program, including— 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(1) salaries, personnel costs, equipment costs, 
and other costs directly related to the operation of 
the program, including the enforcement unit; 
(2) payments for treatment providers that are 
approved by the relevant State or tribal jurisdiction 
and licensed, if necessary, to provide needed treat-
ment to eligible offenders participating in the pro-
gram, including aftercare supervision, vocational 
training, education, and job placement; and 
(3) payments to public and nonprofit private 
entities that are approved by the State or tribal ju-
risdiction and licensed, if necessary, to provide alco-
hol and drug addiction treatment to eligible offend-
ers participating in the program. 
(g) SUPPLEMENT NOT SUPPLANT.—An eligible enti-
ty shall use Federal funds received under this section only 
to supplement the funds that would, in the absence of 
those Federal funds, be made available from other Federal 
and non-Federal sources for the activities described in this 
section, and not to supplant those funds. 
(h) GEOGRAPHIC
DISTRIBUTION.—The Attorney 
General shall ensure that, to the extent practicable, the 
geographical distribution of grants under this section is 
equitable and includes a grant to an eligible entity in— 
(1) each State; 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(2) rural, suburban, and urban areas; and 
(3) tribal jurisdictions. 
(i) REPORTS AND EVALUATIONS.—Each fiscal year, 
each recipient of a grant under this section during that 
fiscal year shall submit to the Attorney General a report 
on the outcomes of activities carried out using that grant 
in such form, containing such information, and on such 
dates as the Attorney General shall specify. 
(j) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of fiscal years 2016 through 2020. 
SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND 
IMPLEMENTATION PILOT. 
(a) DEFINITION.—In this section, the term ‘‘eligible 
entity’’ means a State, local, or tribal law enforcement 
agency. 
(b) PROGRAM AUTHORIZED.—Section 1177 of chap-
ter 16 of Drug Abuse Prevention, Treatment and Reha-
bilitation (21 U.S.C. chapter 16 subchapter IV) is amend-
ed— 
(1) by adding subsection 1177c and inserting 
the following: 
‘‘(c) The Attorney General, in coordination with the 
Secretary of Health and the Attorney General, in coordi-
nation with the Secretary of Health and Human Services 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
and the Director of the Office of National Drug Control 
Policy, may make grants to eligible entities to create a 
pilot law enforcement program to prevent opioid and her-
oin overdose death. 
‘‘(d) APPLICATION.— 
‘‘(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
‘‘(A) that meets the criteria under para-
graph (2); and 
‘‘(B) at such time, in such manner, and 
accompanied by such information as the Attor-
ney General may require. 
‘‘(2) CRITERIA.—An eligible entity, in submit-
ting an application under paragraph (1), shall— 
‘‘(A) describe the evidence-based method-
ology and outcome measurements that will be 
used to evaluate the program funded with a 
grant under this section, and specifically ex-
plain how such measurements will provide valid 
measures of the impact of the program; 
‘‘(B) describe how the program could be 
broadly replicated if demonstrated to be effec-
tive; 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(C) identify the governmental and com-
munity agencies that the program will coordi-
nate; and 
‘‘(D) describe how law enforcement agen-
cies will coordinate with their corresponding 
State substance abuse agency to identify proto-
cols and resources that are available to victims 
and families, including information on treat-
ment and recovery resources. 
‘‘(e) USE OF FUNDS.—An eligible entity shall use a 
grant received under this section to— 
‘‘(1) make naloxone available to be carried and 
administered by law enforcement officers; 
‘‘(2) train and provide resources for law en-
forcement officers on carrying and administering 
naloxone for the prevention of opioid and heroin 
overdose death; and 
‘‘(3) establish processes, protocols, and mecha-
nisms for referral to treatment. 
‘‘(f) GRANT AMOUNTS AND DURATION.— 
‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen-
eral may not award a grant under this section in an 
amount that exceeds $500,000. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(2) DURATION.—The Attorney General shall 
award grants under this section for a period not to 
exceed 2 years. 
‘‘(g) TECHNICAL ASSISTANCE GRANTS.—The Attor-
ney General shall make a grant for the purpose of pro-
viding technical assistance and training on the use of 
naloxone to reverse overdose deaths and mechanisms for 
referral to treatment for an eligible entity receiving a 
grant under this section. 
‘‘(h) EVALUATION.—The Attorney General shall con-
duct an evaluation of grants made under this section to 
determine— 
‘‘(1) the number of officers equipped with 
naloxone for the prevention of fatal opioid and her-
oin overdose; 
‘‘(2) the number of opioid and heroin overdoses 
reversed by officers receiving training and supplies 
of naloxone through a grant received under this sec-
tion; 
‘‘(3) the number of calls for service related to 
opioid and heroin overdose; 
‘‘(4) the extent to which overdose victims and 
families receive information about treatment services 
and available data describing treatment admissions; 
and 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(5) the research, training, and naloxone supply 
needs of law enforcement and first responder agen-
cies, including those agencies that are not receiving 
grants under this section. 
‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of fiscal years 2016 through 2020.’’. 
SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION. 
(a) DEFINITION.—In this section, the term ‘‘eligible 
entity’’ means a State, local, tribal law enforcement agen-
cy, public and private hospitals, pharmacies and other en-
tities approved for prescription drug disposal by the Drug 
Enforcement Agency. 
(b) PROGRAM AUTHORIZED.—Section 1177 of chap-
ter 16 of Drug Abuse Prevention, Treatment and Reha-
bilitation (21 U.S.C. chapter 16 subchapter IV) is amend-
ed— 
(1) by adding subsection 1177d and inserting 
the following: 
‘‘(d) The Attorney General, in coordination with the 
Secretary of Health and the Attorney General, in coordi-
nation with the Administrator of the Drug Enforcement 
Administration, the Secretary of Health and Human Serv-
ices, and the Director of the Office of National Drug Con-
trol Policy, may make grants to eligible entities to expand 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
or make available disposal sites for unwanted prescription 
medications.’’. 
(c) APPLICATION.— 
(1) IN GENERAL.—An eligible entity desiring a 
grant under this section shall submit an application 
to the Attorney General— 
(A) that meets the criteria under para-
graph (2); and 
(B) at such time, in such manner, and ac-
companied by such information as the Attorney 
General may require. 
(2) CRITERIA.—An eligible entity, in submitting 
an application under paragraph (1), shall— 
(A) describe the evidence-based method-
ology and outcome measurements that will be 
used to evaluate the program funded with a 
grant under this section, and specifically ex-
plain how such measurements will provide valid 
measures of the impact of the program; 
(B) describe how the program could be 
broadly replicated if demonstrated to be effec-
tive; and 
(C) identify the governmental and commu-
nity agencies that the project will be coordinate. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(d) USE OF FUNDS.—An eligible entity shall use a 
grant received under this section for— 
(1) expenses of a prescription drug disposal 
site, including materials and resources; 
(2) implementing disposal procedures and proc-
esses; 
(3) implementing community education strate-
gies, including community education materials and 
resources; 
(4) replicating a prescription drug take back 
initiative throughout multiple jurisdictions; and 
(5) training of law enforcement officers and 
other community participants. 
(e) GRANT AMOUNTS AND DURATION.— 
(1) MAXIMUM AMOUNT.—The Attorney General 
may not award a grant under this section in an 
amount that exceeds $250,000. 
(2) DURATION.—The Attorney General shall 
award grants under this section for a period not to 
exceed 2 years. 
(f) TECHNICAL ASSISTANCE GRANT.—The Attorney 
General shall make a grant to a national nonprofit organi-
zation to provide technical assistance and training for an 
eligible entity receiving a grant under this section. 
(g) EVALUATION.— 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
(1) IN GENERAL.—The Attorney General shall 
make a grant for evaluation of the performance of 
each eligible entity receiving a grant under this sec-
tion. 
(2) REPORTS.—Each fiscal year, the recipient 
of a grant under this subsection shall submit to the 
Attorney General a report on the effectiveness of the 
prescription drug take back program of each eligible 
entity receiving a grant under this section. 
(h) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$2,500,000 for each of fiscal years 2016 through 2020. 
TITLE III—TREATMENT AND 
RECOVERY 
SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREAT-
MENT 
AND 
INTERVENTIONS 
DEMONSTRA-
TION. 
Subpart 1 of part B of title V of the Public Health 
Service Act (42 U.S.C. 290bb et seq.) is amended— 
(1) by redesignating section 514 (42 U.S.C. 
290bb–9), as added by section 3632 of the Meth-
amphetamine Anti-Proliferation Act of 2000 (Public 
Law 106–310; 114 Stat. 1236), as section 514B; 
and 
(2) by adding at the end the following: 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREAT-
MENT 
AND 
INTERVENTIONS 
DEMONSTRA-
TION. 
‘‘(a) GRANTS.— 
‘‘(1) AUTHORITY TO MAKE GRANTS.—The Di-
rector of the Center for Substance Abuse Treatment 
(referred to in this section as the ‘Director’) may 
award grants to State substance abuse agencies, 
units of local government, nonprofit organizations, 
and Indian tribes or tribal organizations (as defined 
in section 4 of the Indian Health Care Improvement 
Act (25 U.S.C. 1603)) that have a high rate, or 
have had a rapid increase, in the use of heroin or 
other opioids, in order to permit such entities to ex-
pand activities, including an expansion in the avail-
ability of medication assisted treatment, with respect 
to the treatment of addiction in the specific geo-
graphical areas of such entities where there is a rate 
or rapid increase in the use of heroin or other 
opioids. 
‘‘(2) 
RECIPIENTS.—The 
entities 
receiving 
grants under paragraph (1) shall be selected by the 
Director. 
‘‘(3) NATURE OF ACTIVITIES.—The grant funds 
awarded under paragraph (1) shall be used for ac-
tivities that are based on reliable scientific evidence 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
of efficacy in the treatment of problems related to 
heroin or other opioids. 
‘‘(b) GEOGRAPHIC
DISTRIBUTION.—The Director 
shall ensure that grants awarded under subsection (a) are 
distributed equitably among the various regions of the Na-
tion and among rural, urban, and suburban areas that are 
affected by the use of heroin or other opioids. 
‘‘(c) ADDITIONAL ACTIVITIES.—The Director shall— 
‘‘(1) evaluate the activities supported by grants 
awarded under subsection (a); 
‘‘(2) disseminate widely such significant infor-
mation derived from the evaluation as the Director 
considers appropriate; 
‘‘(3) provide States, Indian tribes and tribal or-
ganizations, and providers with technical assistance 
in connection with the provision of treatment of 
problems related to heroin and other opioids; and 
‘‘(4) fund only those applications that specifi-
cally support recovery services as a critical compo-
nent of the grant program. 
‘‘(d) DEFINITION.—The term ‘medication assisted 
treatment’ means the use, for problems relating to heroin 
and other opioids, of medications approved by the Food 
and Drug Administration in combination with counseling 
and behavioral therapies. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(1) IN GENERAL.—There are authorized to be 
appropriated to carry out this section $10,000,000 
for fiscal year 2016 and such sums as may be nec-
essary for each of fiscal years 2016 through 2020. 
‘‘(2) USE OF CERTAIN FUNDS.—Of the funds 
appropriated to carry out this section in any fiscal 
year, the lesser of 5 percent of such funds or 
$1,000,000 shall be available to the Director for 
purposes of carrying out subsection (c).’’. 
SEC. 
302. 
CRIMINAL 
JUSTICE 
MEDICATION 
ASSISTED 
TREATMENT 
AND 
INTERVENTIONS 
DEM-
ONSTRATION. 
(a) DEFINITIONS.—In this section— 
(1) the term ‘‘criminal justice agency’’ means a 
State, local, or tribal— 
(A) court; 
(B) prison; 
(C) jail; or 
(D) other agency that performs the admin-
istration of criminal justice, including prosecu-
tion, pretrial services, and community super-
vision; and 
(2) the term ‘‘eligible entity’’ means a State, 
unit of local government, or Indian tribe. 
VerDate Sep 11 2014 
22:59 Dec 30, 2014
Jkt 049200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H5845.IH
H5845
mstockstill on DSK4VPTVN1PROD with BILLS